secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspire Biopharma Holdings, Inc. (ASBP)
CIK:        0001847345
Form:       8-K
Filed at:   2023-08-23T23:59:59+00:00
Accession:  0001493152-23-029981
Event type: other_material
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PowerUp Acquisition Corp. changes sponsor, board and officers; new CEO appointed
--------------------------------------------------------------------------------

- New sponsor SRIRAMA Associates acquired 4,317,500 Class A shares and 6,834,333 warrants for $1 total.
- All prior directors (Hack, Tretton, Blacklow, Uhrman, Campbell) and officers resigned.
- Surendra Ajjarapu appointed CEO and Chairman; Howard Doss appointed CFO.
- Trust account true-up payment of ~$0.02/share paid to redeeming shareholders on Aug 18, 2023.
- New independent directors: Michael Peterson, Donald Fell, Mayur Doshi, Avinash Wadhwani.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1847345/000149315223029981/0001493152-23-029981-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1847345/000149315223029981/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-029981

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer